IL6R and diabetic kidney disease: In addition to the paracrine effects, IL-6 can upregulate IL-6R and gp130 in podocytes in an autocrine manner, inducing podocyte dysfunction and injury in DKD (Jo et al., 2016; Lei et al., 2018).